1. Academic Validation
  2. PROTAC-Based Proteomics Strategy Uncovers Arsenic-Binding Proteomes

PROTAC-Based Proteomics Strategy Uncovers Arsenic-Binding Proteomes

  • Anal Chem. 2026 Jun 9;98(22):16501-16511. doi: 10.1021/acs.analchem.6c01761.
Jiahui Liu 1 Ling Fang 2 Shijun Wen 3 Na Zhao 4 Yongshun Huang 4 Hongtao Liu 2 Baowei Chen 5 6 Tiangang Luan 1 6 7
Affiliations

Affiliations

  • 1 State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou 510275, China.
  • 2 Instrumental Analysis and Research Center, Sun Yat-Sen University, Guangzhou 510275, China.
  • 3 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China.
  • 4 Guangdong Province Hospital for Occupational Disease Prevention and Treatment, Guangzhou 510300, China.
  • 5 Southern Marine Science and Engineering Guangdong Laboratory, School of Marine Sciences, Sun Yat-Sen University, Zhuhai 519082, China.
  • 6 Guangdong Provincial Laboratory of Chemistry and Fine Chemical Engineering Jieyang Center, Jieyang 515200, China.
  • 7 School of Environmental and Chemical Engineering, Wuyi University, Jiangmen 529020, China.
Abstract

Manipulating intracellular protein degradation systems provides extraordinary opportunities to find targeting proteins critical for drug discovery, as exemplified by proteolysis-targeting chimeras (PROTACs). Here, using trivalent arsenical-PROTAC (As(III)-PROTAC) probes, we developed an in situ proteolysis strategy to uncover the As-binding proteomes. Combined with proteomic analysis, this strategy identified 135 downregulated proteins in A549 human lung carcinoma cells, providing a candidate list for seeking As-binding proteins. Bioinformatics analysis revealed that they were involved in multiple pathways, such as the tricarboxylic acid cycle, DNA replication, and DNA repair. Karyopherin subunit α-2 (KPNA2) and cyclin-dependent kinase 1 (CDK1) could play core roles in the context of protein interactions. Western blotting confirmed the downregulation of embryonic ectoderm development (EED) and Phospholipase A-2-activating (PLAA) proteins after the probe treatment. A cellular thermal shift assay (CETSA) exhibited intracellular binding of iAsIII to EED and PLAA. This work demonstrates the development and application of PROTAC probes for screening of As-binding proteomes and establishes a methodological foundation for comprehending the biological effects induced by arsenicals.

Figures
Products